Drugs

Promising Newer Molecular-Targeted Therapies in Head and Neck Cancer
pp. 1609-1619(11)
Authors: Wang, Lili X.; Agulnik, Mark

Managing the Patient with Co-Morbid Depression and an Anxiety Disorder
pp. 1621-1634(14)
Authors: Schoevers, Robert A.; Van, Henricus L.; Koppelmans, Vincent; Kool, Simone; Dekker, Jack J.

Endothelin Receptor Antagonism: Role in the Treatment of Pulmonary Arterial Hypertension Related to Scleroderma
pp. 1635-1645(11)
Authors: Kabunga, Peter; Coghlan, Gerry

Platelet Activation, and Antiplatelet Targets and Agents: Current and Novel Strategies
pp. 1647-1664(18)
Authors: Xiang, Yao-Zu; Xia, Ye; Gao, Xiu-Mei; Shang, Hong-Cai; Kang, Li-Yuan; Zhang, Bo-Li

An Evaluation of Eptacog Alfa in Nonhaemophiliac Conditions
pp. 1665-1689(25)
Authors: Mallarkey, Gordon; Brighton, Tim; Thomson, Amanda; Kaye, Karen; Seale, Paul; Gazarian, Madlen

Cevimeline
pp. 1691-1698(8)
Authors: Weber, Juliane; Keating, Gillian M.

Dabigatran Etexilate
pp. 1699-1709(11)
Authors: Sanford, Mark; Plosker, Greg L.

Fentanyl Transdermal Matrix Patch (Durotep® MT Patch; Durogesic® DTrans®; Durogesic® SMAT): In Adults with Cancer-Related Pain
pp. 1711-1721(11)
Authors: Hoy, Sheridan M.; Keating, Gillian M.

Mometasone Furoate: A Review of its Intranasal Use in Allergic Rhinitis
pp. 1723-1739(17)
Authors: Baldwin, Claudine M.; Scott, Lesley J.

Ciclesonide: A Review of its Use in the Management of Asthma
pp. 1741-1770(30)
Authors: Deeks, Emma D.; Perry, Caroline M.